These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

143 related items for PubMed ID: 15010896

  • 21. Effect of human papillomavirus-16 infection on CD8+ T-cell recognition of a wild-type sequence p53264-272 peptide in patients with squamous cell carcinoma of the head and neck.
    Sirianni N, Ha PK, Oelke M, Califano J, Gooding W, Westra W, Whiteside TL, Koch WM, Schneck JP, DeLeo A, Ferris RL.
    Clin Cancer Res; 2004 Oct 15; 10(20):6929-37. PubMed ID: 15501971
    [Abstract] [Full Text] [Related]

  • 22. P53 codon 72 polymorphism in squamous cell carcinoma of the head and neck region.
    Brant O, Hoffmann M, Kanappilly A, Görögh T, Gottschlich S.
    Anticancer Res; 2007 Oct 15; 27(5A):3301-5. PubMed ID: 17970074
    [Abstract] [Full Text] [Related]

  • 23. NF-kappaB gene signatures and p53 mutations in head and neck squamous cell carcinoma.
    Ferris RL, Grandis JR.
    Clin Cancer Res; 2007 Oct 01; 13(19):5663-4. PubMed ID: 17908953
    [No Abstract] [Full Text] [Related]

  • 24. Mutation of p53 in head and neck squamous cell carcinoma correlates with Bcl-2 expression and increased susceptibility to cisplatin-induced apoptosis.
    Andrews GA, Xi S, Pomerantz RG, Lin CJ, Gooding WE, Wentzel AL, Wu L, Sidransky D, Grandis JR.
    Head Neck; 2004 Oct 01; 26(10):870-7. PubMed ID: 15390206
    [Abstract] [Full Text] [Related]

  • 25. High rate of p53 overexpression in head and neck carcinomas detected with a refined ELISA.
    Maass JD, Gottschlich S, Goeroegh T, Bruhn T, Lippert BM, Paulsen JI, Werner JA.
    Anticancer Res; 1997 Oct 01; 17(1A):473-8. PubMed ID: 9066697
    [Abstract] [Full Text] [Related]

  • 26. p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell lines.
    Brachman DG, Beckett M, Graves D, Haraf D, Vokes E, Weichselbaum RR.
    Cancer Res; 1993 Aug 15; 53(16):3667-9. PubMed ID: 8339273
    [Abstract] [Full Text] [Related]

  • 27. Deregulated p21(WAF1) overexpression impacts survival of surgically resected esophageal squamous cell carcinoma patients.
    Goan YG, Hsu HK, Chang HC, Chou YP, Chiang KH, Cheng JT.
    Ann Thorac Surg; 2005 Sep 15; 80(3):1007-16. PubMed ID: 16122475
    [Abstract] [Full Text] [Related]

  • 28. O6-methylguanine-DNA methyltransferase gene: epigenetic silencing and prognostic value in head and neck squamous cell carcinoma.
    Zuo C, Ai L, Ratliff P, Suen JY, Hanna E, Brent TP, Fan CY.
    Cancer Epidemiol Biomarkers Prev; 2004 Jun 15; 13(6):967-75. PubMed ID: 15184253
    [Abstract] [Full Text] [Related]

  • 29. Human papillomavirus and p53 polymorphism in codon 72 in head and neck squamous cell carcinoma.
    Hoffmann M, Scheunemann D, Fazel A, Görögh T, Kahn T, Gottschlich S.
    Oncol Rep; 2009 Mar 15; 21(3):809-14. PubMed ID: 19212643
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Dominant negative p63 isoform expression in head and neck squamous cell carcinoma.
    Sniezek JC, Matheny KE, Westfall MD, Pietenpol JA.
    Laryngoscope; 2004 Dec 15; 114(12):2063-72. PubMed ID: 15564824
    [Abstract] [Full Text] [Related]

  • 32. p53 autoantibodies as tumor marker in head and neck squamous cell cancer.
    Gottschlich S, Hoffmann M, Maass JD, Görörgh T, Buhmann V, Hoffmann-Fazel A, Rudert H, Maune S.
    Anticancer Res; 2003 Dec 15; 23(2A):913-5. PubMed ID: 12820322
    [Abstract] [Full Text] [Related]

  • 33. Prognostic significance of mitotic and apoptotic index and the DNA cytometry in head and neck cancer.
    Smilek P, Dusek L, Veselý K, Rottenberg J, Kostrica R.
    Neoplasma; 2005 Dec 15; 52(3):199-207. PubMed ID: 15875080
    [Abstract] [Full Text] [Related]

  • 34. Inverse correlation between cyclin A1 hypermethylation and p53 mutation in head and neck cancer identified by reversal of epigenetic silencing.
    Tokumaru Y, Yamashita K, Osada M, Nomoto S, Sun DI, Xiao Y, Hoque MO, Westra WH, Califano JA, Sidransky D.
    Cancer Res; 2004 Sep 01; 64(17):5982-7. PubMed ID: 15342377
    [Abstract] [Full Text] [Related]

  • 35. Prognostic significance of epidermal growth factor receptor phosphorylation and mutation in head and neck squamous cell carcinoma.
    Hama T, Yuza Y, Saito Y, O-uchi J, Kondo S, Okabe M, Yamada H, Kato T, Moriyama H, Kurihara S, Urashima M.
    Oncologist; 2009 Sep 01; 14(9):900-8. PubMed ID: 19726454
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Differential diagnosis of pulmonary carcinoma following head and neck cancer by genetic analysis.
    Geurts TW, van Velthuysen ML, Broekman F, van Huysduynen TH, van den Brekel MW, van Zandwijk N, van Tinteren H, Nederlof P, Balm AJ, Brakenhoff RH.
    Clin Cancer Res; 2009 Feb 01; 15(3):980-5. PubMed ID: 19188169
    [Abstract] [Full Text] [Related]

  • 38. Mutational spectra of p53 in geographically localized esophageal squamous cell carcinoma groups in China.
    Cao W, Chen X, Dai H, Wang H, Shen B, Chu D, McAfee T, Zhang ZF.
    Cancer; 2004 Aug 15; 101(4):834-44. PubMed ID: 15305417
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Analysis of p53 status in human cell lines using a functional assay in yeast: detection of new non-sense p53 mutation in codon 124.
    Smardová J, Pavlová S, Svitáková M, Grochová D, Ravcuková B.
    Oncol Rep; 2005 Oct 15; 14(4):901-7. PubMed ID: 16142349
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.